Back

Identification of clinical risk factors and biological markers associated with development of atrial low voltage substrate predisposing to atrial fibrillation. Substrate-AF-Study

18 March 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Atrial fibrillation ablation - Mechanisms and outcomes Arrhythmias, General – Epidemiology, Prognosis, Outcome EHRA Premium Access EHRA 2018

About the speaker

Photo
Doctor Zoraida L Moreno Weidmann

Hospital de la Santa Creu i Sant Pau, Barcelona (Spain)

33 More presentations in this session

Presentation thumbnail
Transformation in rotational atrial activity before and after pulmonary vein isolation
Professor T. Neumann (Nauheim, DE)
Abstract
Presentation thumbnail
Safety of rapid ventricular pacing to acquire three-dimensional rotational angiography during ablation of atrial fibrillation
Doctor A. Billiet (Leuven, BE)
Abstract Slides
Presentation thumbnail
Epicardial ligation of the left atrial appendage for antiarrhythmic indication
Doctor K. Nentwich (Bad Neustadt an der Saale, DE)
Abstract Slides
Presentation thumbnail
Force-Time Integral (FTI) values can predict transmural lesions in left atrium after pulmonary vein isolation in cardiac MRI 3 months post-ablation
Doctor M. Forkmann (Coburg, DE)
Abstract
Presentation thumbnail
Impact of catheter ablation and characteristics of patients with atrial fibrillation and reduced ejection fraction
Doctor A. Vevecka (Würzburg, DE)
Abstract

Access the full session

Session thumbnail
Poster session 1 - Atrial fibrillation ablation - Mechanisms and outcomes

The Event

Event poster

EHRA 2018

18 March - 20 March 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources